hydrea capsule
cheplapharm arzneimittel gmbh - hydroxyurea - capsule - 500mg - hydroxyurea 500mg - antineoplastic agents
vepesid capsule
cheplapharm arzneimittel gmbh - etoposide - capsule - 50mg - etoposide 50mg - antineoplastic agents
dilatrend tablets
cheplapharm arzneimittel gmbh - carvedilol - tablets - 6,25mg
dilatrend tablets
cheplapharm arzneimittel gmbh - carvedilol - tablets - 12,5mg
dilatrend tablets
cheplapharm arzneimittel gmbh - carvedilol - tablets - 25mg
losec mups 10 mg gastro-resistant tablets
cheplapharm arzneimittel gmbh - omeprazole magnesium - gastro-resistant tablet - 10 milligram(s) - proton pump inhibitors; omeprazole
losec mups 20 mg gastro-resistant tablets
cheplapharm arzneimittel gmbh - omeprazole - gastro-resistant tablet - 20 milligram(s) - proton pump inhibitors; omeprazole
losec mups 40 mg gastro-resistant tablets
cheplapharm arzneimittel gmbh - omeprazole - gastro-resistant tablet - 40 milligram(s) - proton pump inhibitors; omeprazole
tandemact
cheplapharm arzneimittel gmbh - pioglitazone, glimepiride - diabetes mellitus, type 2 - drugs used in diabetes - tandemact is indicated for the treatment of patients with type-2 diabetes mellitus who show intolerance to metformin or for whom metformin is contraindicated and who are already treated with a combination of pioglitazone and glimepiride.
competact
cheplapharm arzneimittel gmbh - pioglitazone, metformin hydrochloride - diabetes mellitus, type 2 - drugs used in diabetes - competact is indicated in the treatment of type 2 diabetes mellitus patients, particularly overweight patients, who are unable to achieve sufficient glycaemic control at their maximally tolerated dose of oral metformin alone.